PHM vs XFOR · P/E 7.7, rev $7.39B vs rev $6.5M
PulteGroup Inc (PHM) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
PulteGroup Inc (PHM) is a residential construction company listed on US.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported PHM revenue for 2026-06-30 was $7.39B. Net income was $819.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 154.2% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.
PHM currently screens at market cap $21.92B and trailing P/E 7.7. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the PHM and XFOR stock pages for the full models.
Not investment advice.